首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2222391篇
  免费   166855篇
  国内免费   7378篇
耳鼻咽喉   29695篇
儿科学   71202篇
妇产科学   60000篇
基础医学   308516篇
口腔科学   62014篇
临床医学   199603篇
内科学   441079篇
皮肤病学   52150篇
神经病学   177141篇
特种医学   90444篇
外国民族医学   472篇
外科学   343548篇
综合类   49392篇
现状与发展   3篇
一般理论   657篇
预防医学   168838篇
眼科学   48838篇
药学   165129篇
  10篇
中国医学   4560篇
肿瘤学   123333篇
  2018年   22480篇
  2017年   17790篇
  2016年   20944篇
  2015年   23336篇
  2014年   32246篇
  2013年   47905篇
  2012年   61214篇
  2011年   65371篇
  2010年   39955篇
  2009年   38485篇
  2008年   61018篇
  2007年   65166篇
  2006年   66612篇
  2005年   63916篇
  2004年   61183篇
  2003年   59376篇
  2002年   56889篇
  2001年   112346篇
  2000年   115723篇
  1999年   96606篇
  1998年   26859篇
  1997年   23892篇
  1996年   24660篇
  1995年   24264篇
  1994年   22436篇
  1993年   21134篇
  1992年   77172篇
  1991年   74828篇
  1990年   72636篇
  1989年   69725篇
  1988年   63904篇
  1987年   62612篇
  1986年   59032篇
  1985年   56420篇
  1984年   42058篇
  1983年   35388篇
  1982年   21066篇
  1981年   18650篇
  1980年   17652篇
  1979年   37821篇
  1978年   26598篇
  1977年   23004篇
  1976年   20654篇
  1975年   22313篇
  1974年   26102篇
  1973年   25092篇
  1972年   23490篇
  1971年   21837篇
  1970年   19999篇
  1969年   18991篇
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
71.
72.
73.
74.
75.
76.
77.
78.
79.

Aims

Variations of the anatomy of donor hepatic arteries increase the number of arterial anastomoses during liver transplantation and, possibly, the incidence of hepatic artery thrombosis (HAT). In this study, we describe the arterial anatomic variations in liver grafts procured and transplanted by a single center in Greece, the techniques of arterial anastomosis, and their effect on the incidence of early HAT.

Materials and Methods

From January 2013 to December 2017, the arterial anatomy of 116 grafts procured for liver transplantation were recorded, as well as the technique of arterial anastomosis and the incidence of early hepatic artery thrombosis (HAT <30 days).

Results

A single hepatic artery was recorded in 72.41% of the procured grafts, an aberrant left hepatic artery (accessory or replaced) in 18 grafts (15.52%), and an aberrant right hepatic artery (accessory or replaced) in 17 grafts (14.66%), while other variations were observed in less than 1% of the procured livers. Of the 116 primary liver transplantations, 6 patients (5.17%) developed early HAT <30 days. Two of these patients (1.72%) had 1 anastomosis of the hepatic artery and 4 (3.45%) had 2 anastomoses due to anatomic variations.

Conclusions

Anatomic variations of the hepatic artery in liver grafts is a common finding and increase the incidence of early HAT but not to a degree to make these grafts unusable.  相似文献   
80.
Introduction: Tamoxifen dominates the anti-estrogenic therapy in the early and metastatic breast cancer setting. Tamoxifen has a complex metabolism, being mainly metabolized by CYP2D6 into its 30–100 times more potent metabolite, endoxifen. Recently, a phase I study in which endoxifen as an orally z-endoxifen hydrochloride has been successfully evaluated.

Areas covered: the principal pharmacogenetic and non-genetic differences in the pharmacology of tamoxifen and endoxifen are evaluated. To this end, references from PubMed, Embase or Web of Science, among others, were reviewed As non-genetic factors, important differences and similarities such age, or adherence to tamoxifen therapy are comprehensively illustrated. Additionally, since CYP2D6 genotypes are considered the main limitation of tamoxifen, many studies have investigated the association between the worsened clinical outcomes in patients with non-functional CYP2D6 genotypes. In this review, an overview of the research on this field is presented. Also, a summary describing the literature about individualizing tamoxifen therapy with endoxifen concentrations and its limitations is listed.

Expert opinion: z-endoxifen hydrochloride is only investigated in the metastatic setting, still more research is required before its place in therapeutics is known. Similarly, monitoring tamoxifen efficacy based on endoxifen concentrations might not be overall recommended due to the limited evidence available.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号